×
×
homepage logo
LOGIN
SUBSCRIBE

Business & Tech

FDA approves a second Alzheimer’s drug that can modestly slow disease

WASHINGTON (AP) — U.S. officials have approved another Alzheimer's drug that can modestly slow the disease, providing a new option for patients in the early stages of the incurable, memory-destroying ailment. The Food and Drug Administration approved Eli Lilly's Kisunla on Tuesday for mild ...